Glucagon-Like Peptide-1 Utilization Following Withdrawal of Medicaid Coverage for Weight Loss

This cross-sectional study uses data from Medicaid State Drug Utilization Data to examine associations of coverage withdrawal with Medicaid beneficiaries’ utilization of weight loss–approved glucagon-like peptide-1s.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-11-16
DOI
https://doi.org/10.1001/jama.2026.22008
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Glucagon-Like Peptide-1 Utilization Following Withdrawal of Medicaid Coverage for Weight Loss

Bryant Shuey, Timothy S. Anderson, James Frank Wharam, Elizabeth Nguyen et al.
8 links
JAMA
Diabetes Treatment and Management
article

Glucagon-Like Peptide-1 Utilization Following Withdrawal of Medicaid Coverage for Weight Loss

Bryant Shuey, Timothy S. Anderson, James Frank Wharam, Elizabeth Nguyen, Jing Luo
article en

Abstract

This cross-sectional study uses data from Medicaid State Drug Utilization Data to examine associations of coverage withdrawal with Medicaid beneficiaries’ utilization of weight loss–approved glucagon-like peptide-1s.

JAMA
University of Pittsburgh (US), Duke University (US), VA Pittsburgh Healthcare System (US), Center for Healthcare Evaluation, Research, and Promotion (US), Geisinger Commonwealth School of Medicine (US)
Good health and well-being
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon